There are similarities in the methodologies used for RNAi and other classic genetic techniques, including large-scale screening and targeted hits. A difference, though, might be which phenotypes are scored.The drawbacks and promises would be similar in both cases due to the fact that RNAi screening uses forward genetics with techniques that are reversed.
RNAi screening has established itself as a standard tool in the experimental screening field. Thanks to the growth of the RNAi library and the setting-up of centres for screening, which can automate the process, it is now possible for laboratories to carry-out genome-wide screenings on a wide scale. Screening, however, requires accurate assays, which should be remembered when talking of the efficient and speedy benefits of RNAi methods.Going forward, the RNAi screening process is predicted to be just the start of a wider field of analysis in biology.
]]>Viruses can be weakened, limiting their potential to reproduce within the human body, but still triggering the body’s immune response. This then protects against future infection. Vaccines for measles, mumps and chickenpox are made this way, but these vaccines are not usually suitable for people who already have weakened immune systems.Another option is to inactivate or kill a virus, using a chemical. This means that the virus cannot possibly reproduce within the body, or cause disease and a number of vaccines are created through this strategy, including hepatitis A, rabies and polio. However, a limitation is that several doses are usually required to achieve immunity.Other vaccines are developed by using a small part of the virus or bacteria which causes disease, such as its protein. Hepatitis B and tetanus vaccines are made in this way and a benefit is that they can be given to people who already have weakened immune systems, although like with inactivated viruses, several doses may be necessary.